5U01NS112008-04 |
2022 |
$1548629 |
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance |
5U01NS112008-03 |
2021 |
$745565 |
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance |
3U01NS112008-03S1 |
2021 |
$142746 |
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance |
3U01NS112008-03S2 |
2021 |
$805823 |
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance |
5U01NS112008-02 |
2020 |
$757369 |
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes; Their Progression; and Pathological Relevance |
1U01NS112008-01 |
2019 |
$772770 |
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes; Their Progression; and Pathological Relevance |